Document is current
Any future updates will be listed below
-
Authors
Ninh, V. K. https://orcid.org/0000-0001-6017-4035
Calcagno, D. M.
Yu, J. D.
Zhang, B.
Taghdiri, N.
Sehgal, R. https://orcid.org/0000-0002-3609-7452
Mesfin, J. M. https://orcid.org/0000-0003-1022-8175
Chen, C. J.
Kalhor, K. https://orcid.org/0000-0001-9416-3078
Toomu, A.
Duran, J. M.
Adler, E.
Hu, J.
Zhang, K. https://orcid.org/0000-0002-7596-5224
Christman, K. L. https://orcid.org/0000-0002-6179-898X
Fu, Z.
Bintu, B.
King, K. R. https://orcid.org/0000-0003-1472-2189
- License Information
-
More Information
Article History
Received: 23 April 2023
Accepted: 9 July 2024
First Online: 28 August 2024
Competing interests
: K.L.C. is a cofounder, board member and consultant for, and holds equity interest in Ventrix and Karios Technologies. K.R.K. and V.K.N. hold a patent declaration PCT 114198-5210 on compositions and methods to treat muscle injury and disease.
